70 Results for "

DLD-1

" in MedChemExpress (MCE) Product Catalog:
Products (70)

70 Results for "DLD-1" in MCE Product Catalog:

8
8 Publications Verification
Cat. No.: HY-145669
CAS No.: 113411-17-9
Purity:  99.84%
Target:  

Wnt CDK GSK-3

Research Areas:  

Infection Cancer

DIF-3 is an orally active anticancer agent. DIF-3 reduces the expression levels of cyclin D1 and c-Myc by facilitating their degradation via activation of GSK-3β. DIF-3 inhibits Wnt/β-catenin signaling pathway-related proteins in cells. DIF-3 induces reactive oxygen species (ROS) and autophagy. DIF suppresses the growth of Trypanosoma. cruzi in HT1080 cells. DIF-3 exerts antitumor effects both in vitro and in vivo [1] .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-17598
CAS No.: 22662-39-1
Rafoxanide is a poent, orally active halogenated salicylaniline agent with antiparasitic activity. Rafoxanide interferes with energy metabolism in trematodes by uncoupling oxidative phosphorylation. Rafoxanide is also found to be a potent inhibitor of the BRAF V600E mutant protein, which is important in colorectal cancer. Rafoxanide can be used for the control of infestation with Hemonchus species or Fasciola species in sheep and cattle as well as Oestrus ovis in sheep. Rafoxanide can also be used for cancer research [1] .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-122312
CAS No.: 724440-27-1
Purity:  98.39%
Research Areas:  

Cancer

BAY-8002 is a potent, selective, orally active inhibitor of monocarboxylate transporter 1 (MCT1), with an IC50 of 85 nM in the MCT1-expressing DLD-1 cells, displays excellent selectivity against MCT4. Anti-tumor activity [1].
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-110088
CAS No.: 922150-11-6
Purity:  99.73%
Target:  

MDM-2/p53

Research Areas:  

Cancer

SCH529074 is a potent and orally active p53 activator. SCH529074 binds specifically and conformation-dependently to p53 DBD ( DNA binding domain) with a Ki of 1-2 μM in a saturable manner. SCH529074 restores mutant p53 function and interrupts HDM2-mediated ubiquitination of wild Type p53. SCH529074 can be used for the study of non-small-cell lung carcinoma (NSCLC) [1] .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-122862
CAS No.: 2351843-48-4
Purity:  99.57%
Target:  

Ras

Research Areas:  

Cancer

RAS inhibitor Abd-7, a potent RAS-binding compound (Kd=51 nM), is a RAS-effector protein-protein interaction (PPI) inhibitor. RAS inhibitor Abd-7 interacts with RAS inside the cells, prevents RAS-effector interactions and inhibits endogenous RAS-dependent signaling. RAS inhibitor Abd-7 impairs the PPI of various mutant KRAS proteins with PI3K, CRAF and RALGDS as well as NRAS Q61H and HRAS G12V [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99041
CAS No.: 339177-26-3
Synonyms: ABX-EGF

Target:  

EGFR

Research Areas:  

Cancer

Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer [1] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N2493
CAS No.: 83-72-7
Lawsone is an orally active naphthoquinone dye that can be isolated from the leaves of Lawsonia inermis. Lawsone can induce apoptosis. Lawsone has antibacterial, antitumor and antioxidant activities. Lawsone can be used in anti-tumor drug research [1] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13302
CAS No.: 252003-65-9
Purity:  99.16%
Target:  

VEGFR FGFR

Research Areas:  

Cancer

CP-547632 is an orally active, ATP-competitive and potent VEGFR-2 and FGF kinases inhibitor with IC50s of 11 nM and 9 nM, respectively. CP-547632 is selective for VEGFR2 and bFGF over EGFR, PDGFRβ, and related tyrosine kinases (TKs). CP-547632 has antitumor efficacy [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-114657A
CAS No.: 19428-14-9
Purity:  99.93%
Target:  

Arp2/3 Complex

Research Areas:  

Inflammation/Immunology Cancer

Benproperine phosphate is an orally active, potent actin-related protein 2/3 complex subunit 2 (ARPC2) inhibitor. Benproperine phosphate attenuates the actin polymerization rate of action polymerization nucleation by impairing Arp2/3 function. Benproperine phosphate has the potential for a cough suppressant and suppresses cancer cell migration and tumor metastasis [1].
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13302B
CAS No.: 252003-71-7
Purity:  99.88%
Target:  

VEGFR FGFR

Research Areas:  

Cancer

CP-547632 hydrochloride is an orally active, ATP-competitive and potent VEGFR-2 and FGF kinases inhibitor with IC50s of 11 nM and 9 nM, respectively. CP-547632 hydrochloride is selective for VEGFR2 and bFGF over EGFR, PDGFRβ, and related tyrosine kinases (TKs). CP-547632 hydrochloride has antitumor efficacy [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-164561
CAS No.: 1678515-93-9
Research Areas:  

Cancer

TASIN-30 is a selective EBP inhibitor with an EC50 of 0.097 μM. TASIN-30 blocks the production of 7-dehydrocholesterol (7-DHC) and downstream cholesterol biosynthesis processes. TASIN-30 depletes downstream sterols, disrupts the integrity of lipid rafts in tumor cells, accelerates intracellular cholesterol consumption, and inhibits tumor cell proliferation. TASIN-30 induces ferroptosis and apoptosis by reducing 7-DHC levels and increasing phospholipid peroxidation. TASIN-30 achieves tumor suppression in nude mice with osteosarcoma. TASIN-30 can be used in cancer-related research such as colorectal cancer and osteosarcoma [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136530
CAS No.: 2505001-62-5
Purity:  99.61%
Target:  

KLF

Research Areas:  

Cancer

SR18662 is a potent inhibitor of Krüppel-like factor five (KLF5) with an IC50 of 4.4 nM and an analogue of ML264 (HY-19994) with improved inhibitory potency against colorectal cancer cells. SR18662 can be used for the study of colorectal cancer [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-146052
CAS No.: 2691054-63-2
Purity:  99.23%
Target:  

Atg8/LC3 Autophagy

Research Areas:  

Cancer

Autophagy inducer 3 has autophagy induced activity. Autophagy inducer 3 possesses robust autophagic cell death in diverse cancer cells sparing normal counterpart. Autophagy inducer 3 induces lethal autophagy by formation of characteristic autophagic vacuoles, LC3 puncta formation, upregulation of signature autophagy markers like Beclin and Atg family proteins [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119257
CAS No.: 450839-40-4
Purity:  98.18%
Research Areas:  

Cancer

ABT-100, a chemical probe, is a potent, highly selective and orally active farnesyltransferase inhibitor. ABT-100 inhibits cell proliferation (IC50s of 2.2 nM, 3.8 nM, 5.9 nM, 6.9 nM, 9.2 nM, 70 nM and 818 nM for EJ-1, DLD-1, MDA-MB-231, HCT-116, MiaPaCa-2, PC-3, and DU-145 cells, respectively), increases apoptosis and decreases angiogenesis. ABT-100 possesses broad-spectrum antitumor activity [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2272A
Target:  

Wnt β-catenin

Research Areas:  

Cancer

NLS-StAx-h TFA is a selective, cell permeable, stapled peptide Wnt signaling inhibitor with an IC50 of 1.4 μM. NLS-StAx-h TFA efficiently inhibits β-catenin-transcription factor interactions. NLS-StAx-h TFA shows anti-proliferation of cancer cells [1] .
loading...
    loading...
Cat. No.: HY-P99643
CAS No.: 2390147-17-6
Synonyms: UCB6114

Target:  

Dan family

Research Areas:  

Cancer

Ginisortamab (UCB6114) is a fully human IgG4P anti Gremlin-1 monoclonal antibody, with mean IC50 values of 8.2 nM and 9 nM against human and mouse gremlin-1, respectivly. Ginisortamab inhibits gremlin-1 antagonism of BMP signaling pathways. Ginisortamab has the potential for the research of gastrointestinal (GI) tumors [1] .
loading...
    loading...
Cat. No.: HY-177512
CAS No.: 3098173-17-9
Target:  

FLAP

Research Areas:  

Cancer

MSC778 is an effective and orally active flap endonuclease 1 (FEN1) inhibitor with an IC50 of 3 nM and a KD of 2.9 nM. MSC778 exhibits 145-fold, 516-fold, and 65-fold selectivity over EXO1, GEN1, and XPG, respectively. MSC778 selectively kills BRCA2-deficient cells and potentiates the activity of Niraparib (HY-10619) to induce tumor stasis in a BRCA2 KO DLD-1 mouse xenograft. MSC778 can be used in the research of colorectal cancer [1].
loading...
    loading...
Cat. No.: HY-P99041A

Target:  

EGFR

Research Areas:  

Cancer

Panitumumab (anti-EGFR) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab (anti-EGFR) inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab (anti-EGFR) can be used in the research of cancers, such as colon cancer [1] .
loading...
    loading...
Cat. No.: HY-P991487

Research Areas:  

Inflammation/Immunology

LASN01 is a humanized antibody targeting IL-11R, with a Kd of 37 pM. LASN01 blocks the IL-11 signaling pathway via IL-11Rα, and inhibits the phosphorylation of STAT3 and ERK, as well as the expression of pro-inflammatory cytokines, hyaluronic acid, procollagen and fibrotic markers. LASN01 can be used in studies related to thyroid eye disease [1].
loading...
    loading...
Cat. No.: HY-139691
CAS No.: 2505001-54-5
Purity:  99.95%
Target:  

KLF

Research Areas:  

Cancer

SR15006 is a inhibitor of Krüppel-like factor 5 (KLF5) with an IC50 of 41.6 nM in DLD-1/pGL4.18hKLF5p cells) [1].
loading...
    loading...